Neurodegenerative Diseases |
Request Information |
| Featured Antibody |
|---|
Anti-APP A4 Antibody, a.a. 66-81 of APP , clone 22C11 |
Neurodegenerative Disease with Targets
| ||
|---|---|---|
Alzheimer's Disease |
Key Targets: |
Alzheimer’s Disease is characterized by neuronal loss, alterations in neurotransmitter systems, and the presence of neurofibrillary tangles composed of abnormal tau paired helical filaments. |
Huntington's Disease |
Key Targets: |
Huntington's Disease (HD) is a devastating, hereditary, degenerative brain disorder for which there is, at present, no effective treatment or cure. Huntington’s Disease slowly diminishes the affected individual’s ability. |
Parkinson's Disease |
Key Targets: |
Parkinson’s Disease is a degenerative disorder of the central nervous system that occurs when cells in an area of the brain called the substantia nigra begin to malfunction and die. |
Multiple Sclerosis (MS) |
Key Targets: |
Multiple Sclerosis (MS) is a nerve disorder caused by the autoimmune destruction of the insulating myelin layer surrounding neurons in the brain and spinal cord. |
Acute Injury and Chronic Neurodegeneration |
Key Targets: |
A general feature of many neurological diseases, disorders, or injuries is the degeneration of proximal and/or distal neural processes. |
Brain Inflammation |
Key Targets: |
Whether a massive inflammatory response caused by head injury or a viral infection such as encephalitis or meningitis, or a localized event caused by neurodegenerative disease, inflammation of the central nervous system can cause serious additional neurological damage. |
Reward Pathways & Addiction |
Key Targets: |
Americans view Drug abuse and addiction as the most serious public health problem, above cancer, heart disease, AIDS and even violence. |
Prion Diseases |
Key Targets: |
The prion protein is a large membrane protein that occurs normally in neurons of the human brain and is thought to be involved in synaptic transmission. |